Global Sepsis Diagnostics Market is expected to grow at a CAGR of 9.80% by 2030

Pune, India, July, 2023 /MRFR Press Release/- Market research future published a half-cooked research report on global sepsis diagnostics market. 

Sepsis Diagnostics Market Highlights

Global Sepsis Diagnostics Market is accounted to register a CAGR of 9.80% during the forecast period and is estimated to reach USD 2.32 Billion by 2030.

Sepsis diagnostics refers to the process of identifying and determining the presence of sepsis, a potentially life-threatening condition caused by the body's response to an infection. It involves various diagnostic methods and tests that are used to detect and diagnose sepsis accurately. Sepsis is characterized by a systemic inflammatory response to an infection that can lead to organ dysfunction and failure if not promptly treated. Early and accurate diagnosis of sepsis is crucial for initiating timely and appropriate interventions to improve patient outcomes.

Key Players

MRFR recognizes the following companies as the key players in the Global Sepsis Diagnostics Market— Sandstone Diagnostics Inc, T2 BiosystemsImmunexpress, Axis-Shield Diagnostics Ltd, Becton Dickinson and Company, EKF Diagnostics, Cube Dx GmbH, Wolters Kluwer N.V., Amara Health.

Segment Analysis

The Global Sepsis Diagnostics Market has been segmented based on Technology, Type, and End User.

Based on Technology, the market is segmented into Molecular diagnostics, Biomarkers, and Immunoassays. The Molecular diagnostics category dominates the Sepsis Diagnostics market due to its high sensitivity, specificity, and ability to rapidly identify infectious agents and their antimicrobial resistance patterns, enabling targeted and personalized sepsis management.

Based on Type, the market is segmented into Kits, Instruments, And Blood culture media. The Kits category dominates the Sepsis Diagnostics market due to its convenience, ease of use, and wide availability, allowing for rapid and standardized testing for sepsis in healthcare settings.

Based on End Users, the market is segmented into Pathology laboratories, Specialty clinics, Hospitals, And Diagnostic centers. The Pathology laboratories category dominates the Sepsis Diagnostics market due to its expertise in conducting comprehensive diagnostic tests and providing accurate and timely results for sepsis diagnosis and management.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Sepsis Diagnostics Market Research Report

Regional Analysis

The Global Sepsis Diagnostics Market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Global Sepsis Diagnostics Market comprises Germany, France, the UK, Italy, Spain, and the rest of Europe. The Global Sepsis Diagnostics Market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World's Global Sepsis Diagnostics Market comprises of Middle East, Africa, and Latin America.

The North America Sepsis Diagnostics market reached USD 0.457 billion and is projected to experience a significant compound annual growth rate (CAGR) during the study period. This growth is attributed to the region's increased adoption of advanced diagnostic tools facilitated by a robust healthcare infrastructure. The market expansion in North America is further fueled by the presence of key competitors and a favorable reimbursement system, while the rising prevalence of infectious diseases and sepsis drives the demand for innovative diagnostic methods.

The Europe Sepsis Diagnostics market holds the second-largest market share, driven by increased research and development investments in sepsis diagnostics. Diagnostic labs and centers in the region extensively utilize sepsis diagnostic tools, benefitting from the advanced healthcare system.

The Asia-Pacific Sepsis Diagnostics market is expected to grow at the fastest CAGR from 2022 to 2030. This growth is primarily attributed to the growing demand for sepsis diagnostic tools in countries like Algeria and Morocco, where the incidence of infectious diseases is significant.

Key Findings of the Study

• The Global Sepsis Diagnostics Market is expected to reach USD 2.32 Billion by 2030, at a CAGR of 9.80% during the forecast period.


• The North America Sepsis Diagnostics market reached a value of USD 0.457 billion and is projected to experience a significant compound annual growth rate (CAGR) during the study period. This growth is attributed to the region's increased utilization of advanced diagnostic tools, supported by a strong healthcare infrastructure. The market's expansion is further driven by the presence of key market players and a favorable reimbursement system. Additionally, the rising prevalence of infectious diseases and sepsis is expected to drive the demand for advanced diagnostic methods in North America.


• Based on the Technology, the Market has been segmented into Molecular diagnostics holding the largest market in 2022.


• Sandstone Diagnostics Inc, T2 BiosystemsImmunexpress, Axis-Shield Diagnostics Ltd, Becton Dickinson and Company, EKF Diagnostics, Cube Dx GmbH, Wolters Kluwer N.V., Amara Health.